SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
41 hedge funds and large institutions have $13M invested in SAVIENT PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 9 closing their positions.
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
7% less capital invested
Capital invested by funds: $14.1M → $13M (-$1.04M)
11% less call options, than puts
Call options by funds: $154K | Put options by funds: $173K
13% less funds holding
Funds holding: 47 → 41 (-6)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$100K |
| 2 |
Franklin Resources
San Mateo,
California
|
+$16.5K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$8.33K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$4.91K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$661K |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$635K |
| 3 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$584K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$195K |
| 5 |
Barclays
London,
United Kingdom
|
-$119K |
SVNT Hedge Fund Activity: Q3 2013 in Review
41 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q3 2013, worth a combined $13M — down 7.4% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SVNT and 5 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 12 added.
The largest buyer was Vanguard Group, adding an estimated $100K. The largest seller was Wellington Management Group, cutting an estimated $661K.
- 41 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q3 2013, down from 47 in Q2 2013.
- Funds reported $13M of SAVIENT PHARMACEUTICALS INC stock for Q3 2013, down 7.4% quarter-over-quarter.
- 5 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q3 2013 and 9 closed out, a net change of -4 holders.
- The largest SAVIENT PHARMACEUTICALS INC buyer in Q3 2013 was Vanguard Group, an estimated $100K added.
- The largest SAVIENT PHARMACEUTICALS INC seller in Q3 2013 was Wellington Management Group, an estimated $661K sold.
Based on aggregated 13F filings for Q3 2013.